Viewing Study NCT00932451


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:37 PM
Study NCT ID: NCT00932451
Status: COMPLETED
Last Update Posted: 2017-01-13
First Post: 2009-06-30
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Sponsor: Pfizer
Organization: